May 11 (Reuters) - Cyclacel Pharmaceuticals Inc
CYCC.O :
* CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* CYCLACEL PHARMACEUTICALS INC - AS OF MARCH 31, 2023, PRO
FORMA
CASH AND CASH EQUIVALENTS TOTALED $16.1 MILLION
* CYCLACEL PHARMACEUTICALS INC - ESTIMATES ITS AVAILABLE
CASH WILL
FUND CURRENTLY PLANNED PROGRAMS INTO Q1 OF 2024
* CYCLACEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.47
Source text for Eikon: ID:nGNX72vq9B
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))